To Demonstrate the Safety and Efficacy of Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2014-2016

ABSTRACT

The purpose of this study is to evaluate the safety and efficacy of autologous PRP injection in combination with topical application of PRP gel in treating chronic or non-healing ulcers on lower extremity using a rapid, intra-operative, point-of-care technology at the patient's bedside. Detailed Description Platelet Rich Plasma (PRP) therapy is an innovative treatment that uses body's own cells to relieve pain and promote accelerated healing of Non-healing Foot Ulcer /Wound. The body's response to any tissue injury is to deliver platelets, which play an instrumental role in the normal healing process by secreting growth factors and attracting stem cells—critical components of the healing cascade. Any wound or ulcer on skin that has been present for 4-5 weeks duration, without healing is called a non-healing ulcer. Non-healing ulcers include venous, arterial, diabetic, pressure and traumatic ulcers. Cellular therapies using Autologous Platelet Rich Plasma provides new options for wound healing. The efficacy of the treatment has been proven in surgical applications, in the treatment of severe burns and in transplantation of cells and tissues. Local application of a solution of plasma enriched in platelets derived from the patient's blood intends to trigger the healing process in non-responsive chronic wound, increase the wound repair rate and reduce pain. PRP is a good option for non-healing wounds because it utilizes the body's natural healing processes to jump-start wound healing. Plasma which contains very valuable growth factors is separated from other blood components utilizing a point of care technology based on density gradient centrifugation. The platelet rich plasma is harvested and then activated by a mixture of human thrombin and calcium chloride for initiating the healing cascade followed by PRP injection directly into the ulcer/wound periphery or spread over a wound in the form of a PRP gel. More... »

URL

https://clinicaltrials.gov/show/NCT03026855

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2837", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The purpose of this study is to evaluate the safety and efficacy of autologous PRP injection in combination with topical application of PRP gel in treating chronic or non-healing ulcers on lower extremity using a rapid, intra-operative, point-of-care technology at the patient's bedside.\n\nDetailed Description\nPlatelet Rich Plasma (PRP) therapy is an innovative treatment that uses body's own cells to relieve pain and promote accelerated healing of Non-healing Foot Ulcer /Wound. The body's response to any tissue injury is to deliver platelets, which play an instrumental role in the normal healing process by secreting growth factors and attracting stem cells\u2014critical components of the healing cascade. Any wound or ulcer on skin that has been present for 4-5 weeks duration, without healing is called a non-healing ulcer. Non-healing ulcers include venous, arterial, diabetic, pressure and traumatic ulcers. Cellular therapies using Autologous Platelet Rich Plasma provides new options for wound healing. The efficacy of the treatment has been proven in surgical applications, in the treatment of severe burns and in transplantation of cells and tissues. Local application of a solution of plasma enriched in platelets derived from the patient's blood intends to trigger the healing process in non-responsive chronic wound, increase the wound repair rate and reduce pain. PRP is a good option for non-healing wounds because it utilizes the body's natural healing processes to jump-start wound healing. Plasma which contains very valuable growth factors is separated from other blood components utilizing a point of care technology based on density gradient centrifugation. The platelet rich plasma is harvested and then activated by a mixture of human thrombin and calcium chloride for initiating the healing cascade followed by PRP injection directly into the ulcer/wound periphery or spread over a wound in the form of a PRP gel.", 
    "endDate": "2016-05-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT03026855", 
    "keywords": [
      "safety", 
      "efficacy", 
      "Platelet-Rich Plasma", 
      "non-healing", 
      "topical application", 
      "low extremity", 
      "point-of-care", 
      "patient", 
      "bedside", 
      "therapy", 
      "innovative treatment", 
      "body", 
      "own cell", 
      "pain", 
      "healing", 
      "tissue injury", 
      "Blood Platelet", 
      "instrumental role", 
      "normal healing", 
      "growth factor", 
      "attracting", 
      "Wound and Injury", 
      "ulcer", 
      "skin", 
      "duration", 
      "pressure", 
      "cellular therapy", 
      "option", 
      "wound healing", 
      "surgical application", 
      "severe burn", 
      "transplantation", 
      "cell", 
      "tissue", 
      "local application", 
      "solution", 
      "plasma", 
      "blood", 
      "healing process", 
      "chronic wound", 
      "wound repair", 
      "good option", 
      "non-healing wound", 
      "blood component", 
      "technology", 
      "density gradient centrifugation", 
      "mixture", 
      "thrombin", 
      "chloride", 
      "periphery"
    ], 
    "name": "To Demonstrate the Safety and Efficacy of Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT03026855"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00023.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.417966.b", 
        "type": "Organization"
      }
    ], 
    "startDate": "2014-06-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/s12929-017-0324-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084251120", 
          "https://doi.org/10.1186/s12929-017-0324-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12929-017-0324-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084251120", 
          "https://doi.org/10.1186/s12929-017-0324-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT03026855"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03026855'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03026855'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03026855'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03026855'


 

This table displays all metadata directly associated to this object as RDF triples.

76 TRIPLES      16 PREDICATES      67 URIs      59 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT03026855 schema:about anzsrc-for:2837
2 anzsrc-for:3053
3 schema:description The purpose of this study is to evaluate the safety and efficacy of autologous PRP injection in combination with topical application of PRP gel in treating chronic or non-healing ulcers on lower extremity using a rapid, intra-operative, point-of-care technology at the patient's bedside. Detailed Description Platelet Rich Plasma (PRP) therapy is an innovative treatment that uses body's own cells to relieve pain and promote accelerated healing of Non-healing Foot Ulcer /Wound. The body's response to any tissue injury is to deliver platelets, which play an instrumental role in the normal healing process by secreting growth factors and attracting stem cells—critical components of the healing cascade. Any wound or ulcer on skin that has been present for 4-5 weeks duration, without healing is called a non-healing ulcer. Non-healing ulcers include venous, arterial, diabetic, pressure and traumatic ulcers. Cellular therapies using Autologous Platelet Rich Plasma provides new options for wound healing. The efficacy of the treatment has been proven in surgical applications, in the treatment of severe burns and in transplantation of cells and tissues. Local application of a solution of plasma enriched in platelets derived from the patient's blood intends to trigger the healing process in non-responsive chronic wound, increase the wound repair rate and reduce pain. PRP is a good option for non-healing wounds because it utilizes the body's natural healing processes to jump-start wound healing. Plasma which contains very valuable growth factors is separated from other blood components utilizing a point of care technology based on density gradient centrifugation. The platelet rich plasma is harvested and then activated by a mixture of human thrombin and calcium chloride for initiating the healing cascade followed by PRP injection directly into the ulcer/wound periphery or spread over a wound in the form of a PRP gel.
4 schema:endDate 2016-05-01T00:00:00Z
5 schema:keywords Blood Platelet
6 Platelet-Rich Plasma
7 Wound and Injury
8 attracting
9 bedside
10 blood
11 blood component
12 body
13 cell
14 cellular therapy
15 chloride
16 chronic wound
17 density gradient centrifugation
18 duration
19 efficacy
20 good option
21 growth factor
22 healing
23 healing process
24 innovative treatment
25 instrumental role
26 local application
27 low extremity
28 mixture
29 non-healing
30 non-healing wound
31 normal healing
32 option
33 own cell
34 pain
35 patient
36 periphery
37 plasma
38 point-of-care
39 pressure
40 safety
41 severe burn
42 skin
43 solution
44 surgical application
45 technology
46 therapy
47 thrombin
48 tissue
49 tissue injury
50 topical application
51 transplantation
52 ulcer
53 wound healing
54 wound repair
55 schema:name To Demonstrate the Safety and Efficacy of Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers
56 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03026855
57 schema:sdDatePublished 2019-03-07T15:27
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher Nd4f9d761f06e4ffebda067188bd41bfa
60 schema:sponsor https://www.grid.ac/institutes/grid.417966.b
61 schema:startDate 2014-06-01T00:00:00Z
62 schema:subjectOf sg:pub.10.1186/s12929-017-0324-1
63 schema:url https://clinicaltrials.gov/show/NCT03026855
64 sgo:license sg:explorer/license/
65 sgo:sdDataset clinical_trials
66 rdf:type schema:MedicalStudy
67 Nd4f9d761f06e4ffebda067188bd41bfa schema:name Springer Nature - SN SciGraph project
68 rdf:type schema:Organization
69 anzsrc-for:2837 schema:inDefinedTermSet anzsrc-for:
70 rdf:type schema:DefinedTerm
71 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
72 rdf:type schema:DefinedTerm
73 sg:pub.10.1186/s12929-017-0324-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084251120
74 https://doi.org/10.1186/s12929-017-0324-1
75 rdf:type schema:CreativeWork
76 https://www.grid.ac/institutes/grid.417966.b schema:Organization
 




Preview window. Press ESC to close (or click here)


...